February 7, 2014
The landscape of hepatitis C (HCV) management has undergone a near-fundamental transformation over the past couple of years. As new treatment options puff up like popcorn kernels on a hot stove and our understanding of the virus deepens, it's important to revisit what's changed -- and what further changes 2014 may hold in store.
Late in 2013, Andrea Cox, M.D., Ph.D., an associate professor of medicine at Johns Hopkins University School of Medicine, presented an update on HCV coinfection for an audience of HIV care providers. Read on for a summary of key points from her talk, including selected slides (which have been reposted with her permission).
Myles Helfand is the editorial director of TheBody.com and TheBodyPRO.com.
Follow Myles on Twitter: @MylesatTheBody.
|AIDS 2014 Video Blog #1: At MSM Global Forum, the Shock of Tragedy and the Road Forward|
|Coverage of AIDS 2014: The 20th International AIDS Conference|
|Zero HIV Infections When PrEP Is Taken 4 or More Times a Week|
|AIDS 2014: Julio Montaner on the Proposed 90-90-90 Strategy to Help End HIV (Video)|
|Not So Fast With That Flush: Drugs That Target HIV Reservoirs May Also Impair Killer T Cells|
|Is HIV Superinfection Unhealthy?|